Skip to main content
SpringerLink
Log in

Provenge: MEDCAC endorsement for prostate cancer in US

  • Media release
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Rights and permissions

Reprints and permissions

About this article

Cite this article

Provenge: MEDCAC endorsement for prostate cancer in US. Pharmacoecon. Outcomes News 617, 12 (2010). https://doi.org/10.2165/00151234-201006170-00023

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-201006170-00023

Keywords

Search

Navigation